MISSION

Science
that becomes medicine

VISION

PrimeCell team is working 15 years to discover technologies
to treat unmedical needs of civilisation.

STRATEGY

PrimeCell is the bio-med company focusing on discovering and clinical testing of biological drugs and medicinal technologies, which are changing genes and cells parameters to support regeneration of human tissues and organs.

We are proud to our results
in regenerative medicine

Patients/year

SQM OF OUR LABS

RESEARCH PROJECTS

CORE EMPLOYEES

RESEARCH PLATFORM

NEWS

mHAM 1102 konzultace se SÚKL

Dne 20.8.2020 proběhla konzultace budoucího výrobce a zadavatele KLH léčivého přípravku mHAM 1102 injectable se SÚKL. Za výrobce se zúčastnili: MUDr. Serhiy Forostyak, Ph.D., Chief Scientific Officer Prof. MUDr. Martin[…]

Read more

During Covid-19 Pandemic, Biotech IPOs Already Surpass Record

By Corrie Driebusch, The Wall Street Journal – Aug. 10, 2020 Some investors are wary of run-up and warn of risks to chasing companies at early stages of development So[…]

Read more

Science Café Ostrava: Inovativní přístupy v léčbě nádorových onemocnění

Zveme vás na přednášku a diskusi v rámci projektu Science Café, tentokrát na téma Inovativní přístupy v léčbě nádorových onemocnění. Hostem Science Café bude Mgr. Jiří Pergner, PhD., postdoktorální pracovník na[…]

Read more

Co-operative transfer research

PrimeCell leads co-operative transfer research with prestigious Universities, Science institutions and technology companies around the world.